Incyte Corporation
Incyte Corporation (INCY) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · INCY · as of Mar 31, 2025
Ownership Breakdown
652
Institutional Holders
▼ 25 vs Q4
$11.53B
Total Inst. Value
▼ $1.09B vs Q4
199.78M
Shares Outstanding
freeFloat 99.06%
190.40M
13F Shares Held
▲ 7.76M vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
INCY largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BAKER BROS. ADVISORS LP services-commercial physical & biological research | 30.74M | 15.87% | 15.87% | $1.86T | May 15, 2025 | ▲ 487 |
VANGUARD GROUP INC services-commercial physical & biological research | 20.00M | 10.32% | 10.32% | $1.21T | May 9, 2025 | ▲ 417.3K |
BLACKROCK, INC. services-commercial physical & biological research | 17.43M | 9.00% | 9.00% | $1.06T | May 2, 2025 | ▲ 922.6K |
DODGE & COX services-commercial physical & biological research | 14.86M | 7.67% | 7.67% | $900.04B | May 14, 2025 | ▼ 55.3K |
STATE STREET CORP services-commercial physical & biological research | 10.04M | 5.18% | 5.18% | $607.65B | May 15, 2025 | ▲ 4.3K |
AQR CAPITAL MANAGEMENT LLC services-commercial physical & biological research | 6.74M | 3.48% | 3.48% | $405.79B | May 15, 2025 | ▲ 3.23M |
GEODE CAPITAL MANAGEMENT, LLC services-commercial physical & biological research | 4.21M | 2.17% | 2.17% | $254.01B | May 13, 2025 | ▲ 167.9K |
RENAISSANCE TECHNOLOGIES LLC services-commercial physical & biological research | 3.71M | 1.91% | 1.91% | $224.56B | May 14, 2025 | ▼ 377.2K |
LSV ASSET MANAGEMENT services-commercial physical & biological research | 3.64M | 1.88% | 1.88% | $220.28B | May 9, 2025 | ▲ 170.5K |
INVESCO LTD. services-commercial physical & biological research | 3.17M | 1.64% | 1.64% | $191.87B | May 12, 2025 | ▲ 120.5K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
35
Increased
+12.40M shares1
New Positions
first time holders13
Decreased
−1.73M shares0
Sold Out
fully exitedNet shares change (top 50)
+10.67M
+12.40M / −1.73M
Net new holders
+23
1 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
INCY insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
14
Buy transactions
9
Sell transactions
1.56
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Tray Thomas Principal Accounting Officer | May 26, 2026 | Sale | 2,051 | $97.35 | $199.7K | 21.1K | Form 4 ↗ |
BIENAIME JEAN JACQUES director | May 26, 2026 | Tax Withhold | 13,059 | $97.10 | $1.27M | 22.8K | Form 4 ↗ |
Clancy Paul J director | May 19, 2026 | Sale | 15,000 | $94.93 | $1.42M | 23.7K | Form 4 ↗ |
Stein Steven H CMO & Head of Late-Stage Dev. | May 6, 2026 | Award | 44,124 | — | — | 78.3K | Form 4 ↗ |
CAGNONI PABLO J President, Global Head of R&D | May 6, 2026 | Award | 31,517 | — | — | 266.3K | Form 4 ↗ |
Upadhyay Suketu EVP & Chief Financial Officer | May 4, 2026 | Award | 38,429 | $97.14 | $3.73M | 38.4K | Form 4 ↗ |
Upadhyay Suketu EVP & Chief Financial Officer | May 4, 2026 | Award | 26,343 | — | — | 26.3K | Form 4 ↗ |
Upadhyay Suketu EVP & Chief Financial Officer | May 4, 2026 | Award | 13,171 | — | — | 26.3K | Form 4 ↗ |
CAGNONI PABLO J President, Global Head of R&D | Apr 17, 2026 | Sale | 18,667 | $96.50 | $1.80M | 262.7K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Incyte Corporation (INCY) is primarily owned by institutional investors, who hold approximately 95.3% of total shares outstanding. Company insiders own approximately 0.94%, while retail and public investors account for the remaining 3.76%.
The largest institutional shareholder of Incyte Corporation is BAKER BROS. ADVISORS LP, holding approximately 30.74 million shares — equal to 15.87% of outstanding shares — as of March 31, 2025.
A total of 652 institutional investors currently hold INCY stock, with a combined institutional value of approximately $11.53 billion as of the most recent 13F filing period.
Frequently asked questions
INCY ownershipIncyte Corporation (INCY) is primarily owned by institutional investors, who hold approximately 95.3% of shares. The largest shareholder is BAKER BROS. ADVISORS LP with a 15.87% stake. Company insiders hold 0.94%. Data sourced from SEC Form 13F as of March 31, 2025.